Follow-up of children exposed in utero to 17 alpha-hydroxyprogesterone caproate compared with placebo.
Northen AT, Norman GS, Anderson K, Moseley L, Divito M, Cotroneo M, Swain M, Bousleiman S, Johnson F, Dorman K, Milluzzi C, Tillinghast JA, Kerr M, Mallett G, Thom E, Pagliaro S, Anderson GD; National Institute of Child Health and Human Development (NICHD) Maternal-Fetal Medicine Units (MFMU) Network.
Northen AT, et al. Among authors: norman gs.
Obstet Gynecol. 2007 Oct;110(4):865-72. doi: 10.1097/01.AOG.0000281348.51499.bc.
Obstet Gynecol. 2007.
PMID: 17906021
Clinical Trial.